Site Map
Search Site Content
Contact Us
CBA News
Partner Login
Business Summary
Print Friendly, PDF & Email

Start Up
Investment opportunity in a digital health tech company

Mandate ID: AT-3-MTH-2-2109-5
Transaction Type:
Start Up

Industry: Health/Lifescience


Sector: Clinical research


SIC Code: 87319902 MEDICAL RESEARCH, COMMERCIAL


Country of Origin: Austria |


Target Countries: Austria


Target Areas: European Union


Business Review

9 out 10 clinical trials miss their recruitment goals. 80% out of them are significantly delayed. Low digitalisation and inefficient recruiting methods (notice boards, word of mouth,…) are state of the art. We accelerate research through transparent, informative and attractive access. The company specialises in the recruitment of participants for studies and product tests. Recruitment is done via a online platform. On request, we also recruit survey participants.

Our service:
● Review of all study documents
● Analysing the target audience for recruitment.
● Preparation of a marketing plan for reaching the target group
● Preparing promotional materials for the ethics committee (if submission is required)
● Positioning of the study on our platform
● Top positioning possible after additional charge
● Execution of the advertising measures incl. continuous monitoring and adjustments if necessary
● Sending info mails to suitable potential test persons from our existing database
● Answering and, if necessary, forwarding of questions and comments from participants
● Sending additional material by mail (doodle lists, study information, directions, etc.)
● Assigning appointments
● Regular reporting and consultation with customers

Products
Saas, platform, valuable data for clinical research
Services
Management of clinical trials worldwide , providing critical information to clinical research organisations but also to participants
Financial Information

Revenue 2020: EUR 300,000


Price: EUR 2,5 - 5 Mio Euro


Revenue Multiple 2020: 0.00


Highlights

The start-up has signed a contract with a major pharma player in Europe to become their preferred outsourced partner for clinical trials - this is a paradigms shift in the industry.
The company has started in 2019 and already generates more than 500k Euro in revenues.
The company has signed very promising trials with major players in this field.

Request More Information

searchenvelope-ouserth-listcheckcloselist-altarrows-vtwitter-squarefacebook-squarekeylinkedin-squaregavelbullseyeat